Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.630
-0.010 (-0.61%)
At close: Mar 6, 2026, 4:00 PM EST
1.670
+0.040 (2.45%)
After-hours: Mar 6, 2026, 7:58 PM EST
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $242.88 million as of March 6, 2026. Its market cap has increased by 8,860.00% in one year.
Market Cap
242.88M
Enterprise Value
237.86M
1-Year Change
8,860.00%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $242.88M, an increase of 223.54%. That is a compound annual growth rate of 27.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 242.88M | -30.64% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | 75.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 259.08M |
| Inhibikase Therapeutics | 258.52M |
| Prelude Therapeutics | 257.08M |
| Minerva Neurosciences | 257.05M |
| Orchestra BioMed Holdings | 253.53M |
| Ovid Therapeutics | 240.84M |
| Nuvectis Pharma | 239.48M |
| Camp4 Therapeutics | 238.13M |